Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
However, directionally, if the FDA follows the PCAC recommendations, we ballpark the incremental revenue upside for the 503A channel to be roughly in the hundreds of millions of dollars annually -- potentially scaling to a billion-dollar-plus over time to the extent these therapies approach GLP-1-like telehealth penetration
Click here for updates regarding Coronavirus Pandemic and Your Supplies and a message from our President
Bulletin of Experimental Biology and Medicine, 131(3), 285292
doi: 10.1038/srep37664 (2016)
US$ 29.73
US$ 26.06
US$ 29.24
US$ 28.58
